Management of anticoagulation-associated toxicity during large-volume leukapheresis of peripheral blood stem cell donors [4]

Blood

Volumn 99, Issue 5, 2002, Pages 1878-

  Bolan, Charles D ^a   Leitman, Susan F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM ION; CITRATE CALCIUM; CITRIC ACID; HEPARIN; PARATHYROID HORMONE; POTASSIUM;

ANTICOAGULATION; CENTRAL VENOUS CATHETER; DONOR; HEMATOMA; HUMAN; LETTER; LEUKAPHERESIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOCYTOPHERESIS;

EID: 0036493595     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.5.1878     Document Type: Letter

References (9)

1. Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation
2. Development of apheresis instrumentation
3. Dosage regimens for citrate anticoagulants
4. Physiology of apheresis
5. Comprehensive analysis of citrate effects during plateletpheresis in normal donors
6. Citrate effects and intravenous calcium administration: A controlled study in allogeneic blood stem cell donors undergoing large volume leukapheresis
7. Heparin
8. Allogeneic blood stem cell transplantation: Peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease
9. Large-volume leukapheresis using regional citrate anticoagulation to collect peripheral blood progenitor cells